The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DNA repair mutations and treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) as hallmarks of distinct subgroups of metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team.
 
Rahul Raj Aggarwal
Research Funding - Gilead Sciences; Novartis; Sanofi; Zenith Epigenetics
 
Paul Lloyd
No Relationships to Disclose
 
Jiaoti Huang
No Relationships to Disclose
 
Tomasz M. Beer
Stock and Other Ownership Interests - Salarius Pharmaceuticals
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Clovis Oncology; Dendreon; Janssen; Janssen Biotech; Janssen Oncology; Janssen Research & Development; Johnson & Johnson; Pfizer
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb/Medarex (Inst); Janssen Research & Development (Inst); Medivation/Astellas (Inst); Oncogenex (Inst); Sotio; Sotio (Inst); Theraclone Sciences (Inst)
 
Li Zhang
Consulting or Advisory Role - Dendreon; Fortis
Travel, Accommodations, Expenses - Dendreon
 
George V. Thomas
Patents, Royalties, Other Intellectual Property - Patensts t UCLA and OHSU (Inst)
 
Lawrence D. True
No Relationships to Disclose
 
Joshi J. Alumkal
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen Biotech
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); Gilead Sciences (Inst); Novartis (Inst); Zenith Epigenetics (Inst)
 
Verena Friedl
No Relationships to Disclose
 
Alana Weinstein
No Relationships to Disclose
 
Robert Evan Reiter
Stock and Other Ownership Interests - Inanovate
Consulting or Advisory Role - Astellas Pharma
Patents, Royalties, Other Intellectual Property - patents surrounding discovery of PSCA and N-cadherin, owned by UCLA (Inst)
 
Matthew Rettig
No Relationships to Disclose
 
Primo Lara
Honoraria - Pfizer
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Exelixis; Genentech/Roche; Janssen; Novartis; Pfizer; Turnstone Bio
Research Funding - Aragon Pharmaceuticals (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Incyte (Inst); Janssen Biotech (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Polaris (Inst); TRACON Pharma (Inst)
 
Martin Gleave
Stock and Other Ownership Interests - OncoGenex
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen; Oncogenex; Sanofi
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen; Oncogenex; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427
 
Adam Foye
No Relationships to Disclose
 
Denise Playdle
No Relationships to Disclose
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Consulting or Advisory Role - Celgene; Dendreon; EMD Serono; Ferring; GenomeDx; Janssen Oncology; Medivation/Astellas; Sanofi
Research Funding - Celgene; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Kim N. Chi
Honoraria - Amgen; Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Lilly/ImClone (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst); Tokai Pharmaceuticals (Inst)
 
Josh Stuart
No Relationships to Disclose
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Fortis; Gilead Sciences; Valeant Pharmaceuticals International
Research Funding - Janssen (Inst)